Medicalising unhappiness: new classification of depression risks more patients being put on drug treatment from which they will not benefit

Abstract

ANALYSIS Summary boxClinical context-Diagnoses of major depressive disorder and treatment with antidepressant drugs are increasing Diagnostic change-DSM-III homogenised the diagnosis of depression and the new DSM-5 classification broadens the definition further, allowing the diagnosis of major depressive disorder just two weeks after bereavement Rationale for change-To provide more patients with access to effective treatments Leap of faith-Accurate diagnosis of mild depression is possible; treatment is necessary and leads to better outcomes Increase in disease-Although community prevalence of major depressive disorder has remained static, diagnoses doubled among Medicare recipients in the US between 1992-95 and 2002-05Evidence of overdiagnosis-Depression is now more likely to be overdiagnosed than underdiagnosed in primary care. Rates of prescribing of antidepressant medication doubled in the UK between 1998 and 2010 and in the US 11% of the population aged over 11 now takes an antidepressant. People without evidence of major depressive disorder are being prescribed drug treatment Harms from overdiagnosis-Turning grief and other life stresses into mental disorders represents medical intrusion on personal emotions. It adds unnecessary medication and costs, and distracts attention and resources from those who really need them Limitations-We do not know whether clinicians will follow the DSM-5 proposals Conclusions-Patients with mild depression or uncomplicated grief reaction usually have a good prognosis and don't need drug treatment. Clinicians should focus on identifying people with moderate to severe depressions and sufficient impairment to require treatment.

Anxiety and depression following cumulative low-level exposure to organophosphate pesticides

“…It is possible that the incidence of depression is overestimated if the only measure of depression is a physician's diagnosis (which may even reflect a tendency for over-diagnosis of depression by GPs, e.g. see Dowrick & Frances, 2013). What's more, this type of measure provides no information regarding date of symptom onset and possible triggering factors.…”

Screening for psychiatric morbidity in the population - a comparison of the GHQ-12 and self-reported medication use

“…The finding may also represent an over-prescribing trend by GPs. A relatively recent meta-analysis showed that while GPs were good at ruling out appropriately a diagnosis of depression, the modest prevalence of depression in primary care leads to a high proportion of misclassifications and the potential for over treatment with a rate of false positives that outnumber true positives by about 50% [44,45]. It is possible also that the finding represents a group of patients who have been correctly diagnosed and who are being appropriately treated with a medication that has been effective in treating their symptoms and, therefore, in lowering their GHQ-12 scores.…”

Inclusion of people with psychosocial disability in low and middle income contexts: a practice review

“…2,3,4 In low-and middle-income countries (LMICs), the focus of research has been on the treatment gap, the inequalities in mental health systems, and scaling up access to medical expertise and treatment through task shifting. Whilst these are key considerations, the issues need to be seen through a broader lens that includes the family, community, and social determinants of health and cultural contexts.…”